Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nasonex® Nasal Suspension 50 μg Long-term Designated Drug Use Investigation

NCT00903721 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00903721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00903721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nasonex® Nasal Suspension 50 μg Long-term Designated Drug Use Investigation
Lead sponsor
Organon and Co
Phase
Observational
Overall status
Completed
Start date
November 30, 2008
Completion date
October 31, 2012
Enrollment
3,806 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis